Celebration of NEW Sickle Cell Treatment Endari®


We at The K.I.S. Foundation, Inc., are simply ecstatic to celebrate the U.S. Food and Drug Administration’s approval of Endari®. This marks the the FIRST NEW LIFE-CHANGING TREATMENT for Sickle Cell Disease in almost 20 years! It’s also the first-ever treatment approved for children.


We salute the research and medical advancements of LA BioMed and Emmaus Life Sciences of Torrance for developing this noninvasive medical treatment for #SCD patients!!

Photo-The K.I.S. Foundation Board of Directors (L-R): André Dawson, KiKi Shepard, and Arjay Smith